Fifth Third Bancorp’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 2279 |
|
2018
Q4 | $0 | Sell |
1
-126
| -99% | – | ﹤0.01% | 2325 |
|
2018
Q3 | $10K | Sell |
127
-111
| -47% | -$8.74K | ﹤0.01% | 1833 |
|
2018
Q2 | $18K | Hold |
238
| – | – | ﹤0.01% | 1697 |
|
2018
Q1 | $12K | Hold |
238
| – | – | ﹤0.01% | 1845 |
|
2017
Q4 | $11K | Sell |
238
-813
| -77% | -$37.6K | ﹤0.01% | 1802 |
|
2017
Q3 | $56K | Sell |
1,051
-196
| -16% | -$10.4K | ﹤0.01% | 1257 |
|
2017
Q2 | $77K | Buy |
1,247
+1,178
| +1,707% | +$72.7K | ﹤0.01% | 1148 |
|
2017
Q1 | $5K | Sell |
69
-735
| -91% | -$53.3K | ﹤0.01% | 1852 |
|
2016
Q4 | $57K | Sell |
804
-618
| -43% | -$43.8K | ﹤0.01% | 1290 |
|
2016
Q3 | $101K | Buy |
1,422
+173
| +14% | +$12.3K | ﹤0.01% | 1101 |
|
2016
Q2 | $61K | Sell |
1,249
-111
| -8% | -$5.42K | ﹤0.01% | 1225 |
|
2016
Q1 | $86K | Buy |
+1,360
| New | +$86K | ﹤0.01% | 1140 |
|
2015
Q4 | – | Sell |
-7
| Closed | -$1K | – | 2851 |
|
2015
Q3 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 2775 |
|